# Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference
Canonical URL: https://biopharmsignal.com/news/DCTH/delcath-systems-to-participate-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference
Ticker: DCTH
Company: Delcath Systems
Source: Delcath Systems
Published: 2026-05-12 12:00 EST
Original Source URL: https://delcathsystemsinc.gcs-web.com
## Summary

QUEENSBURY, N.Y. --(BUSINESS WIRE)--May 12, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the H.C.

## Article Body
QUEENSBURY, N.Y. --(BUSINESS WIRE)--May 12, 2026-- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the H.C.
## Recent Company News
- 2026-05-26 20:01 EST — [Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-two-asco-2026-investigator-initiated-trials-in-progress-abstracts) — Source: Delcath Systems
- 2026-05-12 12:00 EST — [Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference](https://biopharmsignal.com/news/DCTH/delcath-systems-to-participate-at-the-h-c-wainwright-4th-annual-bioconnect-investor-conference) — Source: Delcath Systems
- 2026-05-07 12:00 EST — [Delcath Systems Reports First Quarter 2026 Results and Business Highlights](https://biopharmsignal.com/news/DCTH/delcath-systems-reports-first-quarter-2026-results-and-business-highlights) — Source: Delcath Systems
- 2026-05-07 11:00 EST — [Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026](https://biopharmsignal.com/news/DCTH/delcath-systems-announces-presentation-of-new-data-on-percutaneous-hepatic-perfusion-with-melphalan-in-liver-dominant-metastatic-breast-cancer-at-esmo-breast-cancer-2026) — Source: Delcath Systems
- 2026-04-23 12:30 EST — [Delcath Systems to Host First Quarter 2026 Earnings Call](https://biopharmsignal.com/news/DCTH/delcath-systems-to-host-first-quarter-2026-earnings-call) — Source: Delcath Systems
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)